Remifentanil and acute intermittent porphyria [4]

Basit Öğe Kaydı
dc.authorscopusid34569135700
dc.authorscopusid6603931556
dc.authorscopusid6701613323
dc.authorscopusid6603851680
dc.authorscopusid55666804700
dc.authorscopusid7004486274
dc.contributor.authorDurmus M.
dc.contributor.authorTurkoz A.
dc.contributor.authorTogal T.
dc.contributor.authorKoroglu A.
dc.contributor.authorToprak H.I.
dc.contributor.authorErsoy M.O.
dc.date.accessioned2024-08-04T19:59:21Z
dc.date.available2024-08-04T19:59:21Z
dc.date.issued2002
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1097/00003643-200211000-00014
dc.identifier.endpage840en_US
dc.identifier.issn0265-0215
dc.identifier.issue11en_US
dc.identifier.pmid12442938en_US
dc.identifier.scopus2-s2.0-0036829493en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage839en_US
dc.identifier.urihttps://doi.org/10.1097/00003643-200211000-00014
dc.identifier.urihttps://hdl.handle.net/11616/90559
dc.identifier.volume19en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherGreenwich Medical Media Ltden_US
dc.relation.ispartofEuropean Journal of Anaesthesiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectanesthetic agenten_US
dc.subjectbarbituric acid derivativeen_US
dc.subjectbenzodiazepine derivativeen_US
dc.subjectdesfluraneen_US
dc.subjectenfluraneen_US
dc.subjectferrous ionen_US
dc.subjecthalothaneen_US
dc.subjecthemeen_US
dc.subjectinhalation anesthetic agenten_US
dc.subjectisofluraneen_US
dc.subjectnitric oxideen_US
dc.subjectporphobilinogenen_US
dc.subjectporphyrinen_US
dc.subjectpropofolen_US
dc.subjectprotoporphyrinen_US
dc.subjectremifentanilen_US
dc.subjectsevofluraneen_US
dc.subjectthiopentalen_US
dc.subjectacute intermittent porphyriaen_US
dc.subjectadulten_US
dc.subjectanesthesia complicationen_US
dc.subjectanesthesia inductionen_US
dc.subjectbrain diseaseen_US
dc.subjectcase reporten_US
dc.subjectcesarean sectionen_US
dc.subjectdrug clearanceen_US
dc.subjectdrug contraindicationen_US
dc.subjectdrug metabolismen_US
dc.subjectdrug safetyen_US
dc.subjectfemaleen_US
dc.subjectheme synthesisen_US
dc.subjecthigh risk patienten_US
dc.subjecthumanen_US
dc.subjectletteren_US
dc.subjectpathogenesisen_US
dc.subjectporphyrin metabolismen_US
dc.subjectpregnancyen_US
dc.subjectrisk factoren_US
dc.titleRemifentanil and acute intermittent porphyria [4]en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu